We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




The Prostatome – a Novel Prostate Atlas Combining Anatomic and Disease Pathology Data Founded

By LabMedica International staff writers
Posted on 23 Jul 2014
Print article
Image: Prostatome - A prostate atlas derived from MRI showing cancer distribution in vivo relative to the central gland (pink) and peripheral zone (yellow) (Photo courtesy of Prof. Madabhushi, Dr. Rusu, and Case Western Reserve University).
Image: Prostatome - A prostate atlas derived from MRI showing cancer distribution in vivo relative to the central gland (pink) and peripheral zone (yellow) (Photo courtesy of Prof. Madabhushi, Dr. Rusu, and Case Western Reserve University).
Scientists have succeeded in fusing prostate cancer pathology data with anatomical magnetic resonance imaging (MRI) data to create the foundation of a first-of-its-kind prostate atlas for prostate cancer.

A team of scientists and clinicians, led by Anant Madabhushi, professor of biomedical engineering and director of the Center of Computational Imaging and Personalized Diagnostics (CCIPD) at Case Western Reserve University (Cleveland, OH, USA), developed a novel framework, the anatomically constrained registration (AnCoR) scheme, and applied it to perform the fusion of initial data sets for creating the new prostate cancer (PrCa) "prostatome" atlas. The methods developed in the study can now be applied with a larger sample size data set to create a more fully developed atlas, which will allow for highly accurate identification of the MRI signatures associated with PrCa extent and aggressiveness.

The atlas was constructed and validated on 80 patients from two different sites—Boston Medical Center and Beth Israel Deaconess Medical Center. The goal of the study was to integrate pathology and MRI data from multiple different PrCa patients who had undergone surgery involving complete removal of the prostate (radical prostatectomy). All patients had an MRI performed before surgery. The methods developed in this project were used to fuse the MRI scans obtained before surgery with histology data of the surgically excised specimens. This allowed for mapping of cancer extent (determined by a pathologist) in the surgically excised specimen onto the preoperative imaging, enabling construction of a novel PrCa MRI atlas that incorporates PrCa specimen information.

Prof. Madabhushi commented, “The prostatome atlas could allow for integrating imaging data from multiple different patients studies into one unified representation and thereby allow for guiding biopsies, specific treatment targeting, and also serve as an educational tool for medical students and residents.” Additionally, the AnCoR framework could allow for incorporation of complementary imaging and molecular data, thereby enabling their careful correlation for population based radio-omics.

The study, by Rusu M. et al., was described in the July, 2014, issue of the journal Medical Physics.

Related Links:
Case Western Reserve University
Center of Computational Imaging and Personalized Diagnostics



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: The new method could reduce undiagnosed cancer cases in less-developed regions (Photo courtesy of 123RF)

New Method Offers Sustainable Approach to Universal Metabolic Cancer Diagnosis

Globally, more than one billion people suffer from a high rate of missed disease diagnosis, highlighting the urgent need for more precise and affordable diagnostic tools. Such tools are especially crucial... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.